Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 14/20 | 0.98 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.98 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.98 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.76 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| [11C]-Carfentanil SCHEMBL29374424 | 0.99 | OPRM1 (1.00) | OPRM1OPRD1OPRK1CACNA1COPRL1 | |
| Carfentanil SCHEMBL116222 | 0.99 | OPRM1 (1.00) | OPRM1OPRD1OPRK1CACNA1COPRL1 | |
| Carfentanil SCHEMBL4256090 | 0.98 | OPRM1 (0.98) | OPRM1OPRD1OPRK1CACNA1COPRL1 | |
| Carfentanil SCHEMBL9737212 | 0.97 | OPRM1 (0.96) | OPRM1OPRD1OPRK1CACNA1COPRL1 | |
| Carfentanil SCHEMBL16444962 | 0.93 | OPRM1 (0.89) | OPRM1OPRD1OPRK1CACNA1COPRL1 | |
| Carfentanil SCHEMBL4385304 | 0.93 | OPRM1 (0.89) | OPRM1OPRD1OPRK1CACNA1COPRL1 | |
| SCHEMBL11565358 | 0.93 | OPRM1 (0.88) | OPRM1OPRD1OPRK1CACNA1COPRL1 | |
| SCHEMBL11562298 | 0.92 | OPRM1 (0.86) | OPRM1OPRD1OPRK1CACNA1COPRL1 | |
| Hydrochloric Acid SCHEMBL11565447 | 0.92 | OPRM1 (0.86) | OPRM1OPRD1OPRK1CACNA1COPRL1 | |
| SCHEMBL11565468 | 0.92 | OPRM1 (0.86) | OPRM1OPRD1OPRK1CACNA1COPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1633703-B1 | ISOTOPICALLY LABELED CHEMICALLY STABLE REAGENTS AND PROCESS FOR THE SYNTHESIS THEREOF | PERKINELMER LAS INC (US) | 2018-12-26 | — | — | EP | disclosed |
| US-8987501-B2 | Isotopically labeled chemically stable reagents and process for the synthesis thereof | PERKINELMER HEALTH SCIENCES, INC. (US) | 2015-03-24 | — | — | US | disclosed |
| US-20130030184-A1 | ISOTOPICALLY LABELED CHEMICALLY STABLE REAGENTS AND PROCESS FOR THE SYNTHESIS THEREOF | PERKINELMER HEALTH SCIENCES, INC. (US) | 2013-01-31 | — | — | US | disclosed |
| US-8329934-B2 | Isotopically labeled chemically stable reagents and process for the synthesis thereof | PERKINELMER HEALTH SCIENCES, INC. (US) | 2012-12-11 | — | — | US | disclosed |
| US-20120004413-A1 | ISOTOPICALLY LABELED CHEMICALLY STABLE REAGENTS AND PROCESS FOR THE SYNTHESIS THEREOF | PERKINELMER HEALTH SCIENCES, INC. (US) | 2012-01-05 | — | — | US | disclosed |
| US-8058464-B2 | Isotopically labeled chemically stable reagents and process for the synthesis thereof | PERKINELMER HEALTH SCIENCES, INC. (US) | 2011-11-15 | — | — | US | disclosed |
| US-20060205953-A1 | Isotopically labeled chemically stable reagents and process for the synthesis thereof | PERKIN ELMER LAS, INC. (US) | 2006-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130030184-A1 | ISOTOPICALLY LABELED CHEMICALLY STABLE REAGENTS AND PROCESS FOR THE SYNTHESIS THEREOF | ALKBH2, ALKBH3, ALKBH1 | OPRM1 716/4885OPRD1 1225/4885OPRK1 2158/4885 |
| US-20120004413-A1 | ISOTOPICALLY LABELED CHEMICALLY STABLE REAGENTS AND PROCESS FOR THE SYNTHESIS THEREOF | HBG2, ALKBH2, ACVR2B | OPRM1 771/4885OPRD1 1237/4885OPRK1 2117/4885 |
| US-20060205953-A1 | Isotopically labeled chemically stable reagents and process for the synthesis thereof | MRPS23, MRPS22, IPO11 | OPRM1 716/4885OPRD1 1171/4885OPRK1 1191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.